Cargando…
In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
A new severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing coronavirus diseases 2019 (COVID-19), which emerged in Wuhan, China in December 2019, has spread worldwide. Currently, very few treatments are officially recommended against SARS-CoV-2. Identifying effective, low-cost antiviral...
Autores principales: | Gendrot, Mathieu, Jardot, Priscilla, Delandre, Océane, Boxberger, Manon, Andreani, Julien, Duflot, Isabelle, Le Bideau, Marion, Mosnier, Joel, Fonta, Isabelle, Hutter, Sébastien, La Scola, Bernard, Pradines, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307868/ https://www.ncbi.nlm.nih.gov/pubmed/34300178 http://dx.doi.org/10.3390/jcm10143007 |
Ejemplares similares
-
Methylene blue inhibits replication of SARS-CoV-2 in vitro
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate
por: Gendrot, Mathieu, et al.
Publicado: (2020) -
Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022) -
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation
por: Gendrot, Mathieu, et al.
Publicado: (2020)